Gan & Lee Pharmaceuticals Signs Exclusive License Agreement with JW Pharmaceutical, the Leading South Korean Pharma, to Advance the Global Commercialization of the Innovative GLP-1 Receptor Agonist Bofanglutide

BEIJING and BRIDGEWATER, N.J., April 9, 2026 /PRNewswire/ — Gan & Lee…

DXC Introduces New Assure Smart Apps to Accelerate Insurers' AI-Powered Transformation

DXC Assure Smart Apps provide modular, pre-built, AI-driven workflows that deliver business…

NYSE Content Update: Fourth Annual NYSE Sustainability Leaders Summit to Commence

NYSE issues a pre-market daily advisory direct from the trading floor. NEW…

J.S. Held Strengthens Cross-Disciplinary Response to Artificial Intelligence (AI) Disputes

Delivering technical clarity, financial calculus, and courtroom credibility in AI-related litigation. NEW…

Nancy L. Lewis, MD, MBS, FACP, Named New Chief Scientific Officer for National Comprehensive Cancer Network (NCCN)

Accomplished medical research leader will oversee NCCN programs to advance clinical trials…

GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era

The multi-year collaboration aims to scale molecular data storage infrastructure and unlock…

MindHYVE.ai™ and the Development Authority of LaGrange Announce Strategic Collaboration to Advance AI-Powered Workforce Development in Georgia

Partnership brings adaptive AI upskilling to Georgia’s top-ranked economic development community, targeting…

DualityBio Announces China NMPA Acceptance of Biologics License Application Seeking Approval for Trastuzumab Pamirtecan for the Treatment of Unresectable or Metastatic HER2-Positive Adult Breast Cancer

SHANGHAI, April 9, 2026 /PRNewswire/ — DualityBio ("DualityBio" or the "Company", Stock…